In 90 days the NEC infant formula litigation produced a $70 million Cook County verdict against Abbott, an appellate reversal wiping a $60 million St. Clair County award against Mead Johnson, and a St. Louis defense verdict worth zero. Same product category, same science, three answers. Now the first federal NEC jury in American history is hearing the question in Judge Rebecca Pallmeyer's courtroom, with roughly 800 cases stacked behind its verdict form.
On July 2, 2026, a jury in the Circuit Court of the City of St. Louis closed the state courthouse door on Cadence Collins. Her lawyers had spent two weeks arguing that Mead Johnson's Enfamil Premature 24 caused the necrotizing enterocolitis that struck her daughter, born at 25 weeks and 3 days, and in closing they asked for $12 million in compensatory damages plus punitives, according to Law.com's trial coverage. Mead Johnson met the verdict with one sentence: "We strongly reject any assertion that any of our specialized preterm hospital nutrition products cause NEC." The jury's answer was worth zero dollars. Four days later, a new door opened 300 miles northeast: jury selection in the first federal NEC formula trial in American history.
The St. Louis verdict completed a 90-day split that no one pricing mass-tort risk could have scripted. In April, a Cook County jury ordered Abbott Laboratories to pay $70 million to four families over its Similac Special Care 24, with $53 million in compensatory damages and $17 million in punitives, on findings of product defect, failure to warn, and negligence. On June 12, the Illinois Fifth District Appellate Court threw out a $60 million St. Clair County verdict against Mead Johnson and held the company is owed at least a new trial. On July 2, St. Louis found no liability at all. Same category of product. Same body of science. Three venues, three answers.
The record shows what actually moved each outcome, and it was not new science. In St. Louis, the mechanism was the narrowest question in the case. Tucker Ellis, which tried the case for Mead Johnson, reported that the jury foreperson said afterward that jurors "found against plaintiff on specific causation," which the release described as the primary defense asserted at trial. In the St. Clair reversal, the mechanism was a jury instruction. The appellate panel held that Circuit Judge Patrick Foley refused to instruct the jury on the learned intermediary doctrine, the rule that a clinical product maker's duty to warn runs to the treating physicians rather than to the mother, and that the trial admitted an impermissible volume of evidence about Mead Johnson's finances. These cases are turning on verdict forms, instructions, and what a jury is allowed to hear.
Trial drama, nuclear verdicts, and the plaintiff-firm tactics behind them. Court-reporter prose, no consultant filler. Read by litigation leaders at F500 legal departments and national carriers. Free.
The pressure now lands on Judge Rebecca Pallmeyer. She presides over the consolidated preterm infant nutrition MDL in the Northern District of Illinois, where litigation trackers count more than 800 federal cases waiting behind the bellwether. Her courtroom had never let this dispute reach a jury before. All three prior Abbott bellwethers died at summary judgment. Inman v. Mead Johnson is different: Pallmeyer denied summary judgment and preserved the plaintiff's causation expert through the challenges that had ended every earlier federal case. On July 6, the first federal NEC jury was seated. It is hearing the evidence right now.
The tactical map behind the split is now explicit on both sides. The winning defense play in St. Louis, run by a Tucker Ellis team led by Charissa Walker and Sherry Knutson, was specific causation: fight the trace from this product to this child on this record, and let the general science argument stay home. The plaintiff play is the venue table. Cook County and St. Clair County, both fixtures of the American Tort Reform Association's judicial hellhole reports, produced $130 million in combined verdicts against the two manufacturers. Sixty million of that is already gone, and Abbott has said it will appeal the rest. The six-venue nuclear concentration set, a standing entry on the Sentinel's venue watch from the verdict-density research that built it, now faces its first true control experiment: the same causation question, moved out of the counties that price it highest and put to a federal jury under federal expert gatekeeping.
The next fight carries dates. The Inman trial is expected to run about two weeks. On August 10, the second federal bellwether follows on the same Chicago docket, a Similac case brought by the Kelton family, with further bellwethers queued for November 2026 and February 2027. Abbott's appeal of the $70 million Cook County judgment moves in parallel. Jasmine Watson's retrial in St. Clair County waits on a new instruction set that must now include the learned intermediary doctrine.
St. Louis got its answer. Cook County set a number, St. Clair got a do-over, and the formula category that cost Abbott $70 million in Chicago cost Mead Johnson nothing 300 miles south. What no state jury could set is the federal price, because until July 6 no federal jury had ever been allowed to hear the question. A jury in Judge Pallmeyer's courtroom is hearing it now, with roughly 800 cases stacked behind its verdict form and a second jury due August 10. The clock runs.
The Executive Briefing is six questions. It shows you exactly where the gaps are.
Take the Executive Briefing →Trial drama, nuclear verdicts, and the plaintiff-firm tactics behind them. Court-reporter prose, no consultant filler. Read by litigation leaders at F500 legal departments and national carriers. Free.